Full View

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - journals.sagepub.com
Background: Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …
相关文章 Full View

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults.

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - search.ebscohost.com
Background: Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults.

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - europepmc.org
Almost one-third of patients with major depressive disorder (MDD) do not respond to
conventional antidepressants, and new treatments for MDD are urgently needed. This phase …

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu… - Therapeutic …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …
[HTML] nih.gov

[HTML][HTML] A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - ncbi.nlm.nih.gov
Background: Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu, B Wu, M Fang… - 2023 - europepmc.org
Background: Almost one-third of patients with major depressive disorder (MDD) do not
respond to conventional antidepressants, and new treatments for MDD are urgently needed …